From Charité

• Cineus R^#, Luo Y^# (^#shared 1^st authorship), Saliutina M*, Manna S*, Cancino CA* (*shared 2^nd authorship), Velasco Blazquez L, Wang L, Bosel D, Abdelrahman A, Klementowicz JE, Scherl A, Hainbuch S, Breart B, Kwon G, Konopka A, Guerra GM, von Coburg E, Gerbeth L, Roels J, Heinrich F, Müller N, Durek P, Deigendesch N, Ziai J, Hung J, Conrad T; TRR241 IBDome Consortium; Kühl AA, Wirtz S, Löhning M, Keir M, Diefenbach A, Mashreghi MF, Siegmund B, Schumann M, Romagnani C, West NR, Hegazy AN (2025) The IL-22-oncostatin M axis promotes intestinal inflammation and tumorigenesis. Nat. Immunol. 26(6), 837-853. https://doi.org/10.1038/s41590-025-02149-z (°IF 27.6)

• Wiese JJ, Manna S, Kuhl AA, Fasci A, Elezkurtaj S, Sonnenberg E, Bubeck M, Atreya R, Becker C, Weixler B, Siegmund B, Patankar JV, Pruss MS, Schumann M (2024) Myenteric plexus immune cell infiltrations and neurotransmitter expression in Crohn's disease and ulcerative colitis. J. Crohns ad Colitis 18(1), 121-133. https://doi.org/10.1093/ecco-jcc/jjad122 (IF 8.7)

• Branchi F, Wiese JJ, Heldt C, Manna S, Dony V, Loddenkemper C, Bojarski C, Siegmund B, Schneider T, Daum S, Hummel M, Moos V, Schumann M (2022) The combination of clinical parameters and immunophenotyping of intraepithelial lymphocytes allows to assess disease severity in refractory celiac disease. Dig. Liver Dis., 54(12), 1649-1656. https://doi.org/10.1016/j.dld.2022.06.024 (IF 4.5)

• Delbue D, Lebenheim L, Cardoso-Silva D, Dony V, Krug SM, Richter JF, Manna S, Munoz M, Wolk K, Heldt C, Heimesaat M, Sabat R, Siegmund B, Schumann M (2021) Reprogramming intestinal epithelial cell polarity by interleukin-22. Front. Med. (Lausanne) 8: 656047. doi: 10.3389/fmed.2021.656047 (IF 5.1) 

From previous institute

• Chaudhary N, Mandal D, Choudhary BS, Patra S, Jain D, Poonia P, Shaikh S, Tekalkar S, Malvankar S, Shivashankar A, Jog E, Pilankar L, Thorat R, Kailje VV, Khanna S, Manna S, Khan BK, Jadhav A, Sharma K, Ramu S, Sahoo S, Jolly MK, Dalal SN, Sinha S, Nair NU, Ruppin E, Lamballe F, Maina F, Verma N (2025) Low-GPX4 drives a sustained drug-tolerant persister state in TNBC by a targetable adaptive FSP1 upregulation. Redox Biol. 87, 103864. https://doi.org/10.1016/j.redox.2025.103864 (°IF 11.9)

• Chaudhary N, Choudhary BS, Shivashankar A, Manna S, Ved K, Shaikh S, Khanna S, Baar J, Dani J, Sahoo S, Soundharya R, Jolly MK, Verma N (2025) EGFR-to-Src family tyrosine kinase switching in proliferating-DTP TNBC cells creates a hyperphosphorylation-dependent vulnerability to EGFR TKI. Cancer Cell Int. 25(1), 55. https://doi.org/10.1186/s12935-025-03691-4 (°IF 6.0)

• Shaikh N, Pandey M, Manna S, Gawde J, Noronha V, Joshi A, Patil VM, Prabhash K, Mahimkar MB (2025) Evaluating the prognostic value of tumor-derived circulating endothelial cells and their progenitors in platinum-refractory oral cancer patients for response to triple metronomic therapy. Oral Oncol. 165, 107346. https://doi.org/10.1016/j.oraloncology.2025.107346 (°IF 3.9)

• PatelU, Kannan S, Rane SU, Mittal N, Gera P, Patil A, Manna S, Shejwal V, Noronha V, Joshi A, Patil VM, Prabhash K, Mahimkar MB (2022) Prognostic and predictive roles of cancer stem cell markers in head and neck squamous cell carcinoma patients receiving chemoradiotherapy with or without nimotuzumab. Brit. J. Cancer 126(10), 1439-1449. https://doi.org/10.1038/s41416-022-01730-9 (IF 8.8)

• Kunder S, Chatterjee A, Manna S, Mahimkar M, Patil A, Rangarajan V, Budrukkar A, Ghosh-Laskar S, Agarwal JP, Gupta T (2021) Correlation between imaging and tissue biomarkers of hypoxia in squamous cell cancer of the head and neck. World J. Nucl. Med. 20(3), 228-236. https://doi.org/10.4103/wjnm.WJNM_91_20  (no IF)

Back